Aberrant RIP2 activity has been implicated as a driver of inflammation in diseases such as Huntington’s Disease, where it causes increased caspase-1 activation and IL-1β production, ultimately leading to neuronal cell death (Wang et al., 2005). Here, CASP1 is linked to Huntington disease.